Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-19

Clinical Trial Update: Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic study of darunavir/ritonavir with rosuvastatin completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)
  • darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: University of Cincinnati | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-19